Erste Asset Management Gmb H Kala Pharmaceuticals, Inc. Transaction History

Erste Asset Management Gmb H

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 Nov 22, 2024	SELL	$0.61 - $1.84 $64,050 - $193,200	-105,000 Closed	0 $0
Q4 2021 Nov 22, 2024	BUY	$1.16 - $2.74 $121,799 - $287,700	105,000 New	105,000 $122 Million
Q3 2020 Nov 22, 2024	BUY	$7.5 - $11.11 $787,500 - $1.17 Million	105,000 New	105,000 $833 Million
Q2 2020 Nov 22, 2024	BUY	$8.33 - $13.79 $874,650 - $1.45 Million	105,000 New	105,000 $1.08 Billion

Ticker KALA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,464,160
Market Cap $11.3M
Description
Kala Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent...

Get notified when there are updates to the investment portfolio of Erste Asset Management Gmb H, based on Form 13F filings with the SEC.

Stay updated on Erste Asset Management Gmb H with notifications on news.